Emily C. Brantley, Ph.D.
Affiliations: | 2007 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
NeuroimmunologyGoogle:
"Emily Brantley"Mean distance: 21.25 (cluster 6)
Parents
Sign in to add mentor| Etty N. Benveniste | grad student | 2007 | UAB | |
| (Loss of PIAS3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zigler M, Kamiya T, Brantley EC, et al. (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6 |
| Kim SJ, Kim JS, Kim SW, et al. (2011) Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer Neoplasia. 13: 167-179 |
| Brantley EC, Guo L, Zhang C, et al. (2010) Nitric oxide-mediated tumoricidal activity of murine microglial cells. Translational Oncology. 3: 380-8 |
| Brantley EC, Nabors LB, Gillespie GY, et al. (2008) Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4694-704 |
| Brantley EC, Benveniste EN. (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Molecular Cancer Research : McR. 6: 675-84 |